Pablo Elias Gulayin, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypercholesterolemia | 3 | 2019 | 1145 | 0.810 |
Why?
|
| Argentina | 9 | 2024 | 249 | 0.740 |
Why?
|
| Education, Pharmacy | 1 | 2017 | 38 | 0.550 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 2403 | 0.410 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 624 | 0.400 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 829 | 0.380 |
Why?
|
| Health Education | 1 | 2018 | 1059 | 0.380 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 15662 | 0.320 |
Why?
|
| Developing Countries | 3 | 2019 | 2910 | 0.310 |
Why?
|
| Students | 1 | 2018 | 1744 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 3251 | 0.280 |
Why?
|
| Hypertension | 6 | 2021 | 8616 | 0.220 |
Why?
|
| Home Care Services | 2 | 2020 | 659 | 0.200 |
Why?
|
| Telemedicine | 2 | 2019 | 3109 | 0.200 |
Why?
|
| Nitroimidazoles | 1 | 2020 | 118 | 0.160 |
Why?
|
| Chagas Disease | 1 | 2020 | 166 | 0.150 |
Why?
|
| Trypanosoma cruzi | 1 | 2020 | 204 | 0.150 |
Why?
|
| World Health Organization | 1 | 2024 | 1329 | 0.150 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 4045 | 0.140 |
Why?
|
| Guatemala | 3 | 2021 | 161 | 0.130 |
Why?
|
| Risk Factors | 9 | 2024 | 74944 | 0.130 |
Why?
|
| Siblings | 1 | 2018 | 828 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1397 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1567 | 0.090 |
Why?
|
| Blood Pressure | 4 | 2020 | 8543 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1186 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2258 | 0.080 |
Why?
|
| Health Behavior | 1 | 2021 | 2650 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2596 | 0.080 |
Why?
|
| Body Weight | 1 | 2019 | 4627 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6340 | 0.080 |
Why?
|
| Mothers | 1 | 2018 | 2209 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2020 | 24315 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2008 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2019 | 6412 | 0.060 |
Why?
|
| Life Style | 1 | 2018 | 3932 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26379 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2017 | 2187 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 15869 | 0.060 |
Why?
|
| Sex Factors | 1 | 2018 | 10632 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2018 | 5919 | 0.060 |
Why?
|
| Humans | 17 | 2024 | 768166 | 0.060 |
Why?
|
| Middle Aged | 9 | 2021 | 223492 | 0.050 |
Why?
|
| Poverty | 3 | 2020 | 2720 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39348 | 0.050 |
Why?
|
| Exercise | 1 | 2019 | 5955 | 0.050 |
Why?
|
| Time Factors | 3 | 2020 | 40218 | 0.050 |
Why?
|
| Obesity | 1 | 2024 | 13090 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18412 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6211 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2023 | 10399 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 416 | 0.040 |
Why?
|
| Government Programs | 1 | 2021 | 278 | 0.040 |
Why?
|
| Female | 9 | 2021 | 397192 | 0.040 |
Why?
|
| Primary Health Care | 3 | 2021 | 4746 | 0.040 |
Why?
|
| Male | 8 | 2021 | 364719 | 0.040 |
Why?
|
| Adult | 7 | 2023 | 223646 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2017 | 177 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 879 | 0.030 |
Why?
|
| Stroke | 1 | 2018 | 9755 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2021 | 1141 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 171504 | 0.030 |
Why?
|
| Morbidity | 1 | 2020 | 1755 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2020 | 1198 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2018 | 1188 | 0.020 |
Why?
|
| Child | 1 | 2018 | 80917 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 89169 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5315 | 0.020 |
Why?
|
| Health Services Research | 1 | 2015 | 1815 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9669 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2018 | 5107 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8748 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81762 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 30010 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 30256 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41754 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13671 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54926 | 0.010 |
Why?
|